Medically reviewed by Gagandeep Brar, MD Stage 1 and 2 prostate cancer stays in your prostate, and the five-year survival ...

In the US, advanced prostate cancer diagnoses have risen and racial disparities persist, highlighting the continued need for early detection and greater access to curative-intent treatment. A Prostate ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...

Pfizer and Astellas are underlining the benefits of Xtandi as part of a combination therapy for certain patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with an overall survival ...

Excess body weight, as measured by BMI, is associated with improved overall survival (OS) in men with advanced prostate cancer, particularly those with metastatic castration-resistant disease, a ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

In a large study of older US adults, metabolic syndrome marked substantially poorer survival after breast or prostate cancer, highlighting the potential value of integrating metabolic health ...

The researchers had expected to find a link between housing assistance and improved participation in prostate cancer workup and treatment. They were surprised that there were no such significant ...

Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better two-year survival chances compared to demographically and clinically similar men ...